- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x ZN: ZINC ION(Non-covalent)
ZN.7: 6 residues within 4Å:- Chain A: C.479, N.481, C.499, C.506, I.507, C.572
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.479, A:C.499, A:C.506, A:C.572
ZN.8: 7 residues within 4Å:- Chain A: C.477, Q.478, C.479, G.480, N.481, C.482, C.498
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.477, A:C.479, A:C.482, A:C.498
ZN.18: 6 residues within 4Å:- Chain B: C.479, N.481, C.499, C.506, I.507, C.572
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.479, B:C.499, B:C.506, B:C.572
ZN.19: 7 residues within 4Å:- Chain B: C.477, Q.478, C.479, G.480, N.481, C.482, C.498
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.477, B:C.479, B:C.482, B:C.498
ZN.30: 6 residues within 4Å:- Chain C: C.479, N.481, C.499, C.506, I.507, C.572
4 PLIP interactions:4 interactions with chain C- Metal complexes: C:C.479, C:C.499, C:C.506, C:C.572
ZN.31: 7 residues within 4Å:- Chain C: C.477, Q.478, C.479, G.480, N.481, C.482, C.498
4 PLIP interactions:4 interactions with chain C- Metal complexes: C:C.477, C:C.479, C:C.482, C:C.498
- 3 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
GDP.9: 18 residues within 4Å:- Chain A: S.543, R.546, H.547, Y.550, A.564, D.565, F.566, A.567, I.568, L.569, R.574, R.578, K.583, Y.588, S.589, G.590, F.591, K.592
13 PLIP interactions:13 interactions with chain A- Hydrogen bonds: A:H.547, A:Y.550, A:A.567, A:A.567, A:L.569, A:R.574, A:S.589, A:K.592
- Salt bridges: A:R.546, A:R.546, A:R.578, A:K.583
- pi-Stacking: A:F.591
GDP.20: 18 residues within 4Å:- Chain B: S.543, R.546, H.547, Y.550, A.564, D.565, F.566, A.567, I.568, L.569, R.574, R.578, K.583, Y.588, S.589, G.590, F.591, K.592
14 PLIP interactions:14 interactions with chain B- Hydrogen bonds: B:H.547, B:Y.550, B:A.567, B:A.567, B:L.569, B:R.574, B:S.589, B:K.592
- Salt bridges: B:R.546, B:R.546, B:H.547, B:R.578, B:K.583
- pi-Stacking: B:F.591
GDP.32: 18 residues within 4Å:- Chain C: S.543, R.546, H.547, Y.550, A.564, D.565, F.566, A.567, I.568, L.569, R.574, R.578, K.583, Y.588, S.589, G.590, F.591, K.592
14 PLIP interactions:14 interactions with chain C- Hydrogen bonds: C:Y.550, C:A.567, C:A.567, C:L.569, C:R.574, C:S.589, C:K.592
- Salt bridges: C:R.546, C:R.546, C:H.547, C:H.547, C:R.578, C:K.583
- pi-Stacking: C:F.591
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.10: 1 residues within 4Å:- Chain A: N.202
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.202
NAG.11: 3 residues within 4Å:- Chain A: N.213, S.215, C.216
No protein-ligand interaction detected (PLIP)NAG.21: 1 residues within 4Å:- Chain B: N.202
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.202
NAG.22: 3 residues within 4Å:- Chain B: N.213, S.215, C.216
No protein-ligand interaction detected (PLIP)NAG.33: 1 residues within 4Å:- Chain C: N.202
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.202
NAG.34: 3 residues within 4Å:- Chain C: N.213, S.215, C.216
No protein-ligand interaction detected (PLIP)- 3 x Q3G: O-[(R)-[(2S)-2-(hexadecanoyloxy)-3-(octadecanoyloxy)propoxy](hydroxy)phosphoryl]-D-serine(Non-covalent)
Q3G.12: 12 residues within 4Å:- Chain A: F.38, V.41, S.42, I.337, T.340, L.341, F.344, T.348
- Chain B: S.342, Y.343, L.346, V.349
7 PLIP interactions:6 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:F.38, A:V.41, A:L.341, A:L.341, A:L.341, B:L.346
- Hydrogen bonds: A:T.348
Q3G.23: 12 residues within 4Å:- Chain B: F.38, V.41, S.42, I.337, T.340, L.341, F.344, T.348
- Chain C: S.342, Y.343, L.346, V.349
8 PLIP interactions:7 interactions with chain B, 1 interactions with chain C- Hydrophobic interactions: B:F.38, B:V.41, B:I.337, B:L.341, B:L.341, B:L.341, C:L.346
- Hydrogen bonds: B:T.348
Q3G.35: 12 residues within 4Å:- Chain A: S.342, Y.343, L.346, V.349
- Chain C: F.38, V.41, S.42, I.337, T.340, L.341, F.344, T.348
6 PLIP interactions:1 interactions with chain A, 5 interactions with chain C- Hydrophobic interactions: A:L.346, C:F.38, C:V.41, C:L.341, C:L.341
- Hydrogen bonds: C:T.348
- 12 x PLM: PALMITIC ACID(Covalent)
PLM.13: 7 residues within 4Å:- Chain A: L.353, N.356, T.357, S.360
- Chain C: I.337
- Ligands: PLM.14, PLM.15
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:L.353
PLM.14: 6 residues within 4Å:- Chain A: T.357, S.360, C.362, C.363
- Ligands: PLM.13, PLM.15
No protein-ligand interaction detected (PLIP)PLM.15: 10 residues within 4Å:- Chain A: L.353, I.354, T.357, Y.358, C.363, V.367, Y.368
- Ligands: PLM.13, PLM.14, PLM.16
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.353, A:I.354, A:Y.358, A:Y.358
PLM.16: 5 residues within 4Å:- Chain A: Y.358, Y.368, C.371, C.374
- Ligands: PLM.15
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Y.358
PLM.24: 7 residues within 4Å:- Chain A: I.337
- Chain B: L.353, N.356, T.357, S.360
- Ligands: PLM.25, PLM.26
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:L.353
PLM.25: 6 residues within 4Å:- Chain B: T.357, S.360, C.362, C.363
- Ligands: PLM.24, PLM.26
No protein-ligand interaction detected (PLIP)PLM.26: 10 residues within 4Å:- Chain B: L.353, I.354, T.357, Y.358, C.363, V.367, Y.368
- Ligands: PLM.24, PLM.25, PLM.27
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:L.353
PLM.27: 5 residues within 4Å:- Chain B: Y.358, Y.368, C.371, C.374
- Ligands: PLM.26
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:Y.358
PLM.36: 7 residues within 4Å:- Chain B: I.337
- Chain C: L.353, N.356, T.357, S.360
- Ligands: PLM.37, PLM.38
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:L.353
PLM.37: 6 residues within 4Å:- Chain C: T.357, C.362, C.363, V.367
- Ligands: PLM.36, PLM.38
No protein-ligand interaction detected (PLIP)PLM.38: 10 residues within 4Å:- Chain C: L.353, I.354, T.357, Y.358, C.363, V.367, Y.368
- Ligands: PLM.36, PLM.37, PLM.39
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:L.353, C:I.354, C:Y.358
PLM.39: 5 residues within 4Å:- Chain C: Y.358, Y.368, C.371, C.374
- Ligands: PLM.38
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:Y.358
- 3 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.17: 16 residues within 4Å:- Chain A: K.64, V.65, K.66, T.189, V.190, L.191, K.193, I.214, I.228
- Chain B: P.142, Q.143, F.288, P.289, N.292, R.294, K.311
13 PLIP interactions:8 interactions with chain A, 5 interactions with chain B- Hydrogen bonds: A:K.64, A:K.66, A:T.189, B:Q.143, B:N.292
- Salt bridges: A:K.64, A:K.64, A:K.66, A:K.193, B:R.294, B:K.311, B:K.311
- pi-Cation interactions: A:K.66
ATP.28: 15 residues within 4Å:- Chain B: K.64, V.65, K.66, T.189, V.190, L.191, K.193, I.214, I.228
- Chain C: P.142, Q.143, F.288, N.292, R.294, K.311
11 PLIP interactions:4 interactions with chain C, 7 interactions with chain B- Hydrogen bonds: C:N.292, B:K.64, B:K.66, B:T.189
- Salt bridges: C:R.294, C:K.311, C:K.311, B:K.64, B:K.66, B:K.193
- pi-Cation interactions: B:K.66
ATP.29: 16 residues within 4Å:- Chain A: P.142, Q.143, F.288, P.289, N.292, R.294, K.311
- Chain C: K.64, V.65, K.66, T.189, V.190, L.191, K.193, I.214, I.228
12 PLIP interactions:6 interactions with chain C, 6 interactions with chain A- Hydrogen bonds: C:K.64, C:T.189, A:Q.143, A:N.292
- Salt bridges: C:K.64, C:K.66, C:K.193, A:K.145, A:R.294, A:K.311, A:K.311
- pi-Cation interactions: C:K.66
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McCarthy, A.E. et al., Full-Length P2X7Structures Reveal How Palmitoylation Prevents Channel Desensitization. Cell (2019)
- Release Date
- 2019-10-23
- Peptides
- P2X purinoceptor 7: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x ZN: ZINC ION(Non-covalent)
- 3 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x Q3G: O-[(R)-[(2S)-2-(hexadecanoyloxy)-3-(octadecanoyloxy)propoxy](hydroxy)phosphoryl]-D-serine(Non-covalent)
- 12 x PLM: PALMITIC ACID(Covalent)
- 3 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McCarthy, A.E. et al., Full-Length P2X7Structures Reveal How Palmitoylation Prevents Channel Desensitization. Cell (2019)
- Release Date
- 2019-10-23
- Peptides
- P2X purinoceptor 7: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.